TOP TIERMARKET NEWSWIRE
News & sentiment

TG THERAPEUTICS INC (TGTX) — News & AI sentiment

TG THERAPEUTICS INC (TGTX) news roundup. 1 story in the last 24 hours, 2 in the past week, 8 over 30 days. Average 24-hour sentiment is 50/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. US House Periodic Transaction Reports (90-day window): 2 purchases (~$108K) and 2 sales (~$41K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 50/100
7d stories
2
avg sentiment 56.5/100
30d stories
8
avg sentiment 56.5/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
2 buys · 2 sells

Latest stories on TGTX

20h ago
6d ago
Jul 21
Jul 13
TG Therapeutics (TGTX) Starts Phase 2 Briumvi Trial
Yahoo Finance63 · neutralproduct/pr
Jul 9
2 Fast-Growing Pharmaceutical Stocks to Buy Now
The Motley Fool63 · neutralanalyst
Jul 9
Jul 7
Jul 6
Jun 29
Jun 19
Jun 17
Jun 17
TG THERAPEUTICS, INC. (TGTX) files 8-K
SEC 8-K50 · neutralgeneral
Jun 12
Jun 9
Jun 9
Jun 9
Jun 9
Jun 4
Jun 3
Jun 3
Jun 3
Jun 2
Jun 1
May 28
May 28
Open TGTX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →